UC Berkeley spinout Iota Biosciences has obtained $15m in series A capital from investors including Astellas.

Iota Biosciences, a US-based medical device manufacturer spun out of University of California (UC) Berkeley, has closed a $15m series A round backed by investors including pharmaceutical firm Astellas.
Horizons Ventures, Bold Capital Partners, Ironfire and Shanda also supplied capital. The round closed in May 2018, but details were only revealed last week.
Founded in 2017, Iota Biosciences is working on implantable bioelectronic devices, called neural dust, that are the size of a grain of sand.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).